litlas
ログインアカウント作成

Shitij Kapur

1992–2024 年に発表

182
論文数
47,764
被引用数
115
h 指数
179
i10 指数

被引用数

Shitij Kapur の年別被引用数1944 年: 被引用 1 件1973 年: 被引用 3 件1974 年: 被引用 1 件1979 年: 被引用 1 件1983 年: 被引用 1 件1993 年: 被引用 3 件1994 年: 被引用 25 件1995 年: 被引用 59 件1996 年: 被引用 142 件1997 年: 被引用 170 件1998 年: 被引用 257 件1999 年: 被引用 263 件2000 年: 被引用 292 件2001 年: 被引用 299 件2002 年: 被引用 349 件2003 年: 被引用 351 件2004 年: 被引用 339 件2005 年: 被引用 413 件2006 年: 被引用 414 件2007 年: 被引用 399 件2008 年: 被引用 410 件2009 年: 被引用 374 件2010 年: 被引用 507 件2011 年: 被引用 446 件2012 年: 被引用 498 件2013 年: 被引用 551 件2014 年: 被引用 573 件2015 年: 被引用 622 件2016 年: 被引用 599 件2017 年: 被引用 519 件2018 年: 被引用 399 件2019 年: 被引用 1,387 件2020 年: 被引用 1,203 件2021 年: 被引用 961 件2022 年: 被引用 725 件2023 年: 被引用 404 件2024 年: 被引用 744 件2025 年: 被引用 283 件2026 年: 被引用 11 件1945〜1972 年は被引用が無いため表示していません1975〜1978 年は被引用が無いため表示していません1980〜1982 年は被引用が無いため表示していません1984〜1992 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,465 件、この内訳の 25.6%イギリス: 引用元論文 2,223 件、この内訳の 12.7%カナダ: 引用元論文 1,372 件、この内訳の 7.9%ドイツ: 引用元論文 1,141 件、この内訳の 6.5%オーストラリア: 引用元論文 696 件、この内訳の 4%イタリア: 引用元論文 688 件、この内訳の 3.9%オランダ: 引用元論文 665 件、この内訳の 3.8%中国: 引用元論文 652 件、この内訳の 3.7%フランス: 引用元論文 485 件、この内訳の 2.8%スイス: 引用元論文 464 件、この内訳の 2.7%スペイン: 引用元論文 416 件、この内訳の 2.4%日本: 引用元論文 405 件、この内訳の 2.3%
0%25.6%その他 21.7%

機関

分野

  • Neuroscience38.1%
  • Medicine37.1%
  • Psychology10.5%
  • Biochemistry, Genetics and Molecular Biology8.6%
  • Arts and Humanities1%
  • Computer Science0.8%
  • その他3.9%

トピック

  • Schizophrenia research and treatment8.6%
  • Functional Brain Connectivity Studies5.3%
  • Neurotransmitter Receptor Influence on Behavior4.8%
  • Neural and Behavioral Psychology Studies3.7%
  • Memory and Neural Mechanisms3.4%
  • Neuroscience and Neuropharmacology Research3.4%
  • その他70.8%

共著者

全論文

検索で開く
  1. The Dopamine Hypothesis of Schizophrenia: Version III-The Final Common Pathway

    著者: Oliver Howes, Shitij Kapur - Schizophrenia Bulletin 2009 被引用: 2,670

  2. Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia

    著者: Shitij Kapur - American Journal of Psychiatry 2002 被引用: 2,792

  3. Schizophrenia

    著者: Jim van Os, Shitij Kapur - The Lancet 2009 被引用: 1,963

  4. Grand challenges in global mental health

    著者: Pamela Y. Collins, Vikram Patel, Sarah S. Joestl, Dana March, Thomas R. Insel, Abdallah S. Daar, Isabel A. Bordin, E. Jane Costello, Maureen S. Durkin, Christopher Fairburn, Roger I. Glass, Wayne Hall, Yueqin Huang, Steven E. Hyman, Kay Redfield Jamison, Sylvia Kaaya, Shitij Kapur, Arthur Kleinman, Adesola Ogunniyi, Angel A. Otero-Ojeda, Mu‐ming Poo, Vijayalakshmi Ravindranath, Barbara J. Sahakian, Shekhar Saxena, Peter Singer, Dan J. Stein, Warwick P. Anderson, Muhammad A. Dhansay, Wendy Ewart, Anthony G. Phillips, Susan B. Shurin, Mark Walport - Nature 2011 被引用: 2,083

  5. The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment

    著者: Oliver Howes, Joseph Kambeitz, Euitae Kim, Daniel Ståhl, Mark Slifstein, Anissa Abi‐Dargham, Shitij Kapur - Archives of General Psychiatry 2012 被引用: 959

  6. Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it?

    著者: Shitij Kapur, Anthony G. Phillips, Thomas R. Insel - Molecular Psychiatry 2012 被引用: 1,005

  7. Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology

    著者: Sagnik Bhattacharyya, Paul D. Morrison, Paolo Fusar‐Poli, Rocı́o Martı́n-Santos, Stefan Borgwardt, Toby Winton‐Brown, Chiara Nosarti, Colin M O' Carroll, Marc L. Seal, Paul Allen, Mitul A. Mehta, James Stone, Nigel Tunstall, Vincent Giampietro, Shitij Kapur, Robin Murray, Antônio Waldo Zuardi, José Alexandre S. Crippa, Zerrin Atakan, Philip McGuire - Neuropsychopharmacology 2009 被引用: 678

  8. Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment

    著者: Amir Englund, Paul D. Morrison, Judith Nottage, Dominic Hague, Fergus Kane, Stefania Bonaccorso, James Stone, Avi Reichenberg, Rudolf Brenneisen, David Holt, Amanda Feilding, Lucy Walker, Robin Murray, Shitij Kapur - Journal of Psychopharmacology 2012 被引用: 462

  9. Relationship Between Dopamine D2 Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode Schizophrenia

    著者: Shitij Kapur, Robert B. Zipursky, Corey Jones, Gary Remington, Sylvain Houle - American Journal of Psychiatry 2000 被引用: 1,083

  10. CSACI guidelines for the ethical, evidence-based and patient-oriented clinical practice of oral immunotherapy in IgE-mediated food allergy

    著者: Philippe Bégin, Edmond S. Chan, H. Kim, Monika Wagner, Marjo Cellier, Caroline Favron‐Godbout, Elissa M. Abrams, Moshe Ben‐Shoshan, Scott B. Cameron, Stuart Carr, David Fischer, A. Haynes, Shitij Kapur, Marie-Noël Primeau, Julia Upton, Timothy K. Vander Leek, Mireille Goetghebeur - Allergy Asthma and Clinical Immunology 2020 被引用: 183

  11. Antipsychotic Treatment Resistance in Schizophrenia Associated with Elevated Glutamate Levels but Normal Dopamine Function

    著者: Arsime Demjaha, Alice Egerton, Robin Murray, Shitij Kapur, Oliver Howes, James Stone, Philip McGuire - Biological Psychiatry 2013 被引用: 344

  12. Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study

    著者: René S. Kahn, Inge Winter van Rossum, Stefan Leucht, Philip McGuire, Shôn Lewis, Shon W Lewis, Celso Arango, Paola Dazzan, Richard Drake, Stephan Heres, Covadonga M. Díaz‐Caneja, Covadonga M Díaz-Caneja, Mark Weiser, Silvana Galderisi, Birte Glenthøj, Marinus J.C. Eijkemans, W. Wolfgang Fleischhacker, Shitij Kapur, Iris E. Sommer, René S. Kahn, Iris E. Sommer, Inge Winter-van Rossum, Metten Somers, Paula C Ywema, S. Kapur, Philip McGuire, Shitisj Kapur, Andreas Meyer‐Lindenberg, Shôn Lewis, Stefan Leucht, Celso Arango, Wolfgang Fleischhacker, Anne Lotte Meijering, Jocelyn Petter, Resy van de Brug, Joost Schotsman, Jildou Zwerver, Jos Peuskens, Jildou Zwerver, E Thys, Lucho G Hranov, Valentin Hranov, Jan Libiger, Richard M. Köhler, Pavel Mohr, Birte Glenthøj, Brian V. Broberg, Signe Wegmann Düring, Lone Baandrup, Stéphane Jamain, Lone Baandrup, Stephane Jamain, Ina Giegling, Dan Rujescu, M Heim, Michael Davidson, Mor Bar Heim, Paola Bucci, Armida Mucci, Janusz Rybakowski, Agnieszka Remlinger-Molenda, Ilan Gonen, Paull Radu, Marina Díaz‐Marsá, Alberto González Rodríguez, Tomás Palomo, Roberto Rodríguez–Jiménez, Tomas Palomo, Miquel Bernardo, Julio Bobes, Christina Vilares Oliveira, Gregor Berger, Claudia Wildt, Paola Dazzan, Roccio Perez-Iglesias, Richard Drake, Sarah Gregory, Danielle Wilson, Covadonga M. Díaz‐Caneja, Marinus J.C. Eijkemans, Covadonga M. Díaz‐Caneja, Marinus J.C. Eijkemans - The Lancet Psychiatry 2018 被引用: 197

  13. Determinants of treatment response in first-episode psychosis: an 18F-DOPA PET study

    著者: Sameer Jauhar, Mattia Veronese, Matthew M. Nour, Maria Rogdaki, Pamela Hathway, Federico Turkheimer, James Stone, Alice Egerton, Philip McGuire, Shitij Kapur, Oliver Howes - Molecular Psychiatry 2018 被引用: 183

  14. CNVs conferring risk of autism or schizophrenia affect cognition in controls

    著者: Hreinn Stefánsson, Andreas Meyer‐Lindenberg, Stacy Steinberg, Brynja B. Magnúsdóttir, Katrin Morgen, Sunna Arnarsdóttir, Gyða Björnsdóttir, G. Bragi Walters, Guðrún A. Jónsdóttir, Orla Doyle, Heike Tost, O. Grimm, Solveig Kristjansdottir, Heimir Snorrason, Solveig Davidsdottir, Lárus J. Gudmundsson, Guðbjörn F. Jónsson, Berglind Stefánsdóttir, Isafold Helgadottir, Magnús Haraldsson, Birna Jónsdóttir, Johan H. Thygesen, Adam J. Schwarz, Michael Didriksen, Tine B. Stensbøl, Michael Brammer, Shitij Kapur, Jónas G. Halldórsson, Stefán Hreiðarsson, Evald Sæmundsen, Engilbert Sigurðsson, Kari Stefansson - Nature 2013 被引用: 735

  15. Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation

    著者: Oliver Howes, Francis Vergunst, Siobhan Gee, Philip McGuire, Shitij Kapur, David Taylor - The British Journal of Psychiatry 2012 被引用: 354

  16. Dopamine Synthesis Capacity in Patients With Treatment-Resistant Schizophrenia

    著者: Arsime Demjaha, Robin Murray, Philip McGuire, Shitij Kapur, Oliver Howes - American Journal of Psychiatry 2012 被引用: 346

  17. Does Fast Dissociation From the Dopamine D2Receptor Explain the Action of Atypical Antipsychotics?: A New Hypothesis

    著者: Shitij Kapur, Philip Seeman - American Journal of Psychiatry 2001 被引用: 1,129

  18. Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA)

    著者: Alice Egerton, Anna Murphy, J Donocik, Adriana Anton, Gareth J. Barker, Tracy Collier, J.F.W. Deakin, Richard Drake, Emma Eliasson, Richard Emsley, Catherine J. Gregory, Kira Griffiths, Shitij Kapur, Laura Kassoumeri, Laura Knight, Emily Lambe, Stephen M. Lawrie, Jane Lees, Shôn Lewis, David J Lythgoe, Julian C. Matthews, Philip McGuire, Lily McNamee, Scott Semple, Alexander D. Shaw, Krish D. Singh, Charlotte Stockton-Powdrell, Peter S. Talbot, Mattia Veronese, Ernest H. Wagner, James Walters, S. R. Williams, James H. MacCabe, Oliver Howes - Schizophrenia Bulletin 2020 被引用: 95

  19. Efficacy and safety of adjunctive bitopertin versus placebo in patients with suboptimally controlled symptoms of schizophrenia treated with antipsychotics: results from three phase 3, randomised, double-blind, parallel-group, placebo-controlled, multicentre studies in the SearchLyte clinical trial programme

    著者: Dragana Bugarski‐Kirola, Nakao Iwata, Snjezana Sameljak, Carol Reid, Thomas Blaettler, Laurie Millar, Tiago Reis Marques, George Garibaldi, Shitij Kapur - The Lancet Psychiatry 2016 被引用: 96

  20. Dopaminergic Function in Cannabis Users and Its Relationship to Cannabis-Induced Psychotic Symptoms

    著者: Michael Bloomfield, Celia J. A. Morgan, Alice Egerton, Shitij Kapur, H. Valerie Curran, Oliver Howes - Biological Psychiatry 2013 被引用: 221

  21. The Effect of Paroxetine on 5-HT2A Receptors in Depression: An [18F]Setoperone PET Imaging Study

    著者: Jeffrey H. Meyer, Shitij Kapur, Beata S. Eisfeld, Gregory M. Brown, Sylvain Houle, Jean DaSilva, Alan A. Wilson, Shahryar Rafi‐Tari, HS Mayberg, Sidney H. Kennedy - American Journal of Psychiatry 2001 被引用: 233

  22. NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D2 and serotonin 5-HT2 receptors—implications for models of schizophrenia

    著者: Shitij Kapur, Philip Seeman - Molecular Psychiatry 2002 被引用: 462

  23. An Algorithm-Based Approach to First-Episode Schizophrenia

    著者: Ofer Agid, Tamara Arenovich, Gautam Sajeev, Robert B. Zipursky, Shitij Kapur, George Foussias, Gary Remington - The Journal of Clinical Psychiatry 2011 被引用: 223

  24. From dopamine to salience to psychosis—linking biology, pharmacology and phenomenology of psychosis

    著者: Shitij Kapur, Romina Mizrahi, Ming Li - Schizophrenia Research 2005 被引用: 509